FK778 in Experimental Xenotransplantation: A Detailed Analysis of Drug Efficacy

Journal of Heart and Lung Transplantation

Volumn 26, Issue 1, 2007, Pages 70-77

  Schrepfer, Sonja ^a,c   Deuse, Tobias ^a   Koch Nolte, Friedrich ^b   Krieger, Thorsten ^b   Haddad, Munif ^b   Schäfer, Hansjörg ^b   Pelletier, Marc P ^c   Robbins, Robert C ^c   Reichenspurner, Hermann ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; COMPLEMENT; COMPLEMENT COMPONENT C5; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BLOOD VESSEL WALL; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; GRAFT REJECTION; HAMSTER; HEART PERFUSION; HEART TRANSPLANTATION; HISTOLOGY; HOST CELL; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; IMMUNOFLUORESCENCE; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MALE; MIXED LYMPHOCYTE REACTION; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; RECIPIENT; T LYMPHOCYTE; UPREGULATION; XENOTRANSPLANTATION;

ALKYNES; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; AORTA, ABDOMINAL; CRICETINAE; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; ISOXAZOLES; MALE; NITRILES; RATS; RATS, INBRED BN; RATS, INBRED LEW; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 33846212324     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.10.013     Document Type: Article

References (34)

1. Vasu S., Kelly P., and Lawson W.E. Anemia in heart failure-a concise review. Clin Cardiol 28 (2005) 454-458
2. Evans R.W. Coming to terms with reality: why xenotransplantation is a necessity. In: Platt J. (Ed). Xenotransplantation (2001), ASM Press, Washington, DC 29-51
3. Taniguchi S., and Cooper D.K. Clinical xenotransplantation: past, present and future. Ann R Coll Surg Engl 79 (1997) 13-19
4. Dwyer K.M., Cowan P.J., and d'Apice A.J. Xenotransplantation. Past achievements and future promise. Heart Lung Circ 11 (2002) 32-41
5. Lai L., Kolber-Simonds D., Park K.W., et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295 (2002) 1089-1092
6. Kuwaki K., Tseng Y.L., Dor F.J., et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 11 (2005) 29-31
7. Schuurman H.J., Pino-Chavez G., Phillips M.J., Thomas L., White D.J., and Cozzi E. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors. Transplantation 73 (2002) 1146-1151
8. Cozzi E., Bosio E., Seveso M., Vadori M., and Ancona E. Xenotransplantation-current status and future perspectives. Br Med Bull 75 (2006) 99-114
9. Chen G., Qian H., Starzl T., et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 11 (2005) 1295-1298
10. Zhang Z., Bedard E., Luo Y., et al. Animal models in xenotransplantation. Expert Opin Invest Drugs 9 (2000) 2051-2068
11. Cooper D.K., Gollackner B., Knosalla C., and Teranishi K. Xenotransplantation-how far have we come?. Transplant Immunol 9 (2002) 251-256
12. Bach F.H., Platt J.L., and Cooper D.K.C. Accommodation: the role of natural antibody and complement in discordant xenograft rejection: methods of removal of preformed natural antibodies. In: Kemp D.K.C.E., Reemtsma K., and White D.J.G. (Eds). Xenotransplantation: the transplantation of organs and tissues between species (1991), Springer, Berlin 81-99
13. Hansen A.B., Kirkeby S., Aasted B., et al. The resistance of delayed xenograft rejection to alpha(1,3)-galactosyltransferase gene inactivation and CD4 depletion in a mouse-to-rat model. APMIS 111 (2003) 1019-1026
14. Mancini G., Carbonara A.O., and Heremans J.F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2 (1965) 235-254
15. Briffa N.P., Shorthouse R., Chan J., et al. Histological and immunological characteristics of, and the effect of immunosuppressive treatment on, xenograft vasculopathy. Xenotransplantation 11 (2004) 149-159
16. Vanrenterghem Y., van Hooff J.P., Klinger M., et al. The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients. Transplantation 78 (2004) 9-14
17. Taylor D.O., Barr M.L., Meiser B.M., Pham S.M., Mentzer R.M., and Gass A.L. Suggested guidelines for the use of tacrolimus in cardiac transplant recipients. J Heart Lung Transplant 20 (2001) 734-738
18. Groetzner J., Meiser B., Landwehr P., et al. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure. Transplantation 77 (2004) 568-574
19. Soulillou J.P. How and when will cardiac xenotransplantation enter the clinic?. The recurrent debate has gained in realism. Nat Clin Pract Cardiovasc Med 2 (2005) 550-551
20. Ghebremariam Y.T., Smith S.A., Anderson J.B., Kahn D., and Kotwal G.J. Intervention strategies and agents mediating the prevention of xenorejection. Ann NY Acad Sci 1056 (2005) 123-143
21. Kirschfink M., and Mollnes T.E. Modern complement analysis. Clin Diagn Lab Immunol 10 (2003) 982-989
22. Baldwin W.M., Ota H., and Rodriguez E.R. Complement in transplant rejection: diagnostic and mechanistic considerations. Semin Immunopathol 25 (2003) 181-197
23. Huber-Lang M., Sarma J.V., Zetoune F.S., et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12 (2006) 682-687
24. Song Z., Zhang J., Bennet W., and Wennberg L. Tacrolimus inhibits discordant islet xenograft rejection: a study in the pig-to-rat model. Xenotransplantation 10 (2003) 628-634
25. Khalpey Z., Koch C.A., and Platt J.L. Xenograft transplantation. Anesthesiol Clin N Am 22 (2004) 871-885
26. Kurrle R., Ruuth E., Bartlett R., Lauffer L., and Schorlemmer H.U. Malononitrilamides inhibit T- and B-cell responsiveness in different species. Transplant Proc 29 (1997) 1302-1303
27. Lin Y., Vandeputte M., and Waer M. Suppression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats. Transplantation 65 (1998) 332-339
28. Allaire E., Mandet C., Bruneval P., Bensenane S., Becquemin J.P., and Michel J.B. Cell and extracellular matrix rejection in arterial concordant and discordant xenografts in the rat. Transplantation 62 (1996) 794-803
29. Yamada K., Sachs D.H., and DerSimonian H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 155 (1995) 5249-5256
30. Sebille F., Guillet M., Brouard S., et al. T-cell-mediated rejection of vascularized xenografts in the absence of induced anti-donor antibody response. Am J Transplant 1 (2001) 21-28
31. Scheringa M., Buchner B., de Bruin R.W., et al. Chronic rejection of concordant aortic xenografts in the hamster-to-rat model. Transplant Immunol 4 (1996) 192-197
32. Dambrin C., Klupp J., and Morris R.E. Pharmacodynamics of immunosuppressive drugs. Curr Opin Immunol 12 (2000) 557-562
33. Andres A., Toso C., Morel P., et al. Phylogenetic disparity influences the predominance of direct over indirect pathway of antigen presentation in islet xenotransplantation. Transplant Proc 37 (2005) 463-465
34. Deuse T., Schrepfer S., and Reichenspurner H. The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent. Transplantation 77 (2004) 509-513